t 588 has been researched along with caffeine in 1 studies
Studies (t 588) | Trials (t 588) | Recent Studies (post-2010) (t 588) | Studies (caffeine) | Trials (caffeine) | Recent Studies (post-2010) (caffeine) |
---|---|---|---|---|---|
32 | 0 | 1 | 25,501 | 2,393 | 6,825 |
Protein | Taxonomy | t 588 (IC50) | caffeine (IC50) |
---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | 7.25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimura, T; LlinĂ¡s, RR; Sugimori, M | 1 |
1 other study(ies) available for t 588 and caffeine
Article | Year |
---|---|
Purkinje cell long-term depression is prevented by T-588, a neuroprotective compound that reduces cytosolic calcium release from intracellular stores.
Topics: Animals; Caffeine; Calcium; Central Nervous System Stimulants; Cytosol; Diethylamines; Male; Mice; Mice, Inbred ICR; Neural Inhibition; Neuroprotective Agents; Purkinje Cells; Thiophenes | 2005 |